Chiedu Nchekwube
Family Medicine · Merrillville, INNPI 1790871341
Payments from drug & device makers
Across 215 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$661
- Vanda Pharmaceuticals Inc.$370
- AbbVie$135
- Amarin Pharma, Inc.$133
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$131
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,532100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 59 | $1,027 |
| Novo Nordisk | 51 | $661 |
| Vanda Pharmaceuticals Inc. | 12 | $370 |
| AbbVie(2 entities) | 8 | $135 |
| Amarin Pharma, Inc. | 9 | $133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $131 |
| Boehringer Ingelheim | 6 | $100 |
| Lilly USA, LLC | 7 | $97 |
| Novartis | 5 | $71 |
| GSK | 4 | $68 |
| Sunovion Pharmaceuticals Inc. | 5 | $66 |
| Therapeuticsmd, Inc. | 3 | $64 |
| Exact Sciences | 3 | $63 |
| Johnson & Johnson(2 entities) | 4 | $60 |
| Phadia US Inc. | 4 | $58 |
| Upsher-smith Laboratories LLC | 3 | $51 |
| Abbott | 3 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Amgen | 2 | $35 |
| Dexcom, Inc. | 2 | $32 |
| Pfizer | 2 | $30 |
| Hikma Pharmaceuticals USA | 2 | $28 |
| Ardelyx, Inc. | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Watermark Medical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Si-bone, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$3,538 in reported general payments places this provider in the 80th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $124,098 |
| FarxigaDapagliflozin Propanediol | 69 | $78,732 |
| JardianceEmpagliflozin | 28 | $36,960 |
| EliquisApixaban | 28 | $32,196 |
| JanuviaSitagliptin Phosphate | 25 | $28,045 |
| TradjentaLinagliptin | 21 | $13,853 |
| VascepaIcosapent Ethyl | 20 | $13,567 |
| EntrestoSacubitril/Valsartan | 14 | $12,693 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $11,725 |
| Icosapent Ethyl | 32 | $6,943 |
| Pentoxifylline | 134 | $3,091 |
| ProgesteroneProgesterone, Micronized | 81 | $3,064 |
| Naltrexone Hcl | 60 | $3,025 |
| Selegiline Hcl | 32 | $2,518 |
| Omega-3 Acid Ethyl Esters | 11 | $1,918 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $661 | $124,09870 claims |
| AstraZenecaFarxiga | $1,027 | $78,73269 claims |
| Boehringer IngelheimJardiance, Tradjenta | $100 | $50,81349 claims |
| PfizerEliquis | $30 | $32,19628 claims |
| MerckJanuvia | $16 | $28,04525 claims |
| NovartisEntresto | $71 | $12,69314 claims |
| GSKTrelegy Ellipta | $68 | $11,72515 claims |
| AbbVieArmour Thyroid, Synthroid | $135 | $2,09529 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $17 | $92516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Merrillville
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.